Alembic announces seed round investment in RIGImmune, Inc
Alembic has acquired preferred stock in RIGImmune amounting to a 19.97 per cent post-money stake in the first closing of the…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.